Biochemistry is part of Basic Sciences in the Vanderbilt University School of Medicine. Basic Sciences is comprised of the departments biochemistry, cell and developmental biology, pharmacology, and molecular physiology and biophysics. Learn more about our thriving research community by clicking the buttons below.
The Department of Biochemistry is dedicated to discovering the fundamental mechanisms of biological processes, bridging these discoveries with clinical applications to improve human health, and training the next generation of biomedical scientists. Our investigators are leaders in applying advanced approaches in structural biology, mass spectrometry, chemical biology, cell biology, and genetics to thematic areas like DNA and RNA metabolism, cell division, enzymology, molecular cancer biology, signaling, toxicology, and metabolism. We are united in seeking molecular answers to biomedical questions.
The Department has 26 primary investigator-track faculty and another ~50 secondary, educator, and research-track faculty. An exceptional group of graduate, medical, and undergraduate students and large cohort of post-doctoral fellows train in our laboratories supported by over $30M in funding.
As one of four basic science departments in the School of Medicine Basic Sciences, Biochemistry benefits from being affiliated with a large medical center and medical school as well as Colleges of Arts and Sciences, Engineering, and Connected Computing. Our unique structure allows us to strategically invest in infrastructure, initiatives, and people to fulfill our missions of research, education, and service.
Biochemistry investigators have received major awards including election to the National Academy of Sciences, and a Nobel Prize in Physiology or Medicine (Stanley Cohen, 1986). Our culture of excellence, collaboration, innovation, rigor, dedication, inclusiveness, ambition, kindness, and resiliency facilitates high impact research, education, and service. – David Cortez, Chair
We invite queries regarding graduate studies, postdoctoral training, and faculty positions.
A recent article about the Biochemistry Department can be found here.
Dr. Katrin Karbstein has been named Vice Chair of Biochemistry.
Riley Carter (Mitchell lab) has been named a 2025 VICB Ambassador Travel Award recipient.
Dr. Martin Egli has been award the Richard Armstrong Professorship of Innovation in Biochemistry.
Kate Clowes Moster (Sanders lab) was awarded the 2026 Karpay Award in Structural Biology.
Dec 17, 2025-The world is in the midst of an antibiotic crisis. As wily bacteria develop resistance to one drug after another, pharma companies are forced to play a game of antibacterial whack-a-mole, attempting to develop new drugs to kill them faster than they can mutate. “Every year, some 1.5 million people die from antibiotic resistant infections,” says Neil Osheroff, John G. Coniglio Chair in Biochemistry at Vanderbilt University. “By 2050, it is estimated that that number will grow to 10 million.”
Dec 2025-James M. Dewar is worried about his frog guy.
Dewar, an assistant professor of biochemistry at Vanderbilt University, researches the genetic causes of cancer and aging with the goal of developing better cancer treatments. And that requires frog eggs. Lots of them.
Oct. 30, 2025—Chancellor Daniel Diermeier and Vice Chancellor of People, Culture and Belonging Sydney Savion presented awards at the 2025 Fall Staff Assembly to a mix of inspiring individuals and teams who have made significant contributions through their community engagement, research and service.
Contact the Biochemistry and Chemical Biology Undergraduate Major Program at https://as.vanderbilt.edu/bcb